Xuebijing and somatostatin against acute pancreatitis: A systematic review and network pharmacology

被引：0
作者：
Cao, Ji-Ping [1 ,2 ]
Piao, Xiang-Hua [3 ]
Zhu, Long-Xun [1 ,2 ]
Feng, Pan-Feng [1 ,2 ]
机构：
[1] Nantong Univ, Affiliated Hosp 2, Dept Pharm, 6 Haierxiang North Rd, Nantong 226001, Jiangsu, Peoples R China
[2] First Peoples Hosp Nantong City, Nantong, Jiangsu, Peoples R China
[3] Jiangwan Hosp Shanghai Hongkou Dist, Dept Pharm, Shanghai, Peoples R China
来源：
MEDICINE | 2024年 / 103卷 / 50期
关键词：
acute pancreatitis; meta-analysis and network pharmacology; somatostatin; Xuebijing injection; METAANALYSIS;
D O I：
10.1097/MD.0000000000040964
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background:Acute pancreatitis (AP) is a common pancreatic disease. Xuebijing injection (XBJ) combined with somatostatin in the treatment of AP is frequently used in clinical practice. There is, however, a lack of high-quality evidence-based evidence and network pharmacology to regard the therapeutic efficacy and pharmacological mechanisms. Purpose:The purpose of this study is to investigate the potential therapeutic targets and pharmacological mechanism of XBJ in AP using integrating evidence-based medicine and network pharmacology. Methods:PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, Weipu, and Wanfang databases were searched. Randomized controlled trials of XBJ combined with somatostatin (experimental group) versus somatostatin alone (control group) in the treatment of AP were collected. After extracting data from the literature that meets the inclusion criteria, and using the Cochrane Scale to evaluate the quality of the literature, we used Rev Man 5.3.0 statistical software to perform meta-analysis of the effective rate, the disappearance time of abdominal pain and bloating, the recovery of gastrointestinal motility, serum-related indicators, inflammatory factors, ventilator evacuation time, and hospitalization time. A network pharmacology is used to analyze the potential active ingredients and related crucial targets of the XBJ in the treatment of AP, and we explored key regulatory pathways and potential biomarkers related to XBJ for AP with integrated bioinformatics analysis. Results:It was significant that the total effective rate in the study group was higher than that in the control group (P < .05). The time of recovery of gastrointestinal motility, serum-related indicators, inflammatory factors, ventilator withdrawal time, and hospitalization time were significantly lower than that of the control group. The differences were statistically significant (P < .05). Signal transducer and activator of transcription 3, tumor protein P53, interleukin 6, tumor necrosis factor, Jun Proto-Oncogene, SRC Proto-Oncogene, Heat Shock Protein 90 Alpha Family Class A Member 1, Vascular Endothelial Growth Factor A, Epidermal Growth Factor Receptor, and Mitogen-Activated Protein Kinase 1 were identified as the key hub of the protein-protein interaction network according to an analysis of network centrality. According to the Kyoto Encyclopedia of Genes and Genomes pathway analysis, the main pathways are involved in PI3K-Akt signaling pathway, HIF-1 signaling pathway, and tumor necrosis factor signaling pathway. Conclusions:The effectiveness of combination therapy of XBJ and somatostatin on AP is likely to be better than somatostatin. In addition, XBJ and somatostatin synergistically treated AP through a multi-pathway network.
引用
收藏
页数：11
相关论文
共 26 条
  • [11] Zuo L., Sun Z., Hu Y., Rapid determination of 30 bioactive constituents in XueBiJing injection using ultra high performance liquid chromatography-high resolution hybrid quadrupole-orbit rap mass spectrometry coupled with principal component analysis., J Pharm Biomed Anal, 137, pp. 220-228, (2017)
  • [12] Cui X.Y., Zhang L., Zhang S.P., Effect of Xuebijing injection combined with somatostatin on inflammatory factors and adverse reactions in patients with acute pancreatitis., Health Med Res Prac, 19, pp. 24-27, (2022)
  • [13] Mao X., Xu H., Li S., Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network., Phytomedicine, 54, pp. 159-168, (2019)
  • [14] Stewart L.A., Clarke M., Rovers M., Preferred reporting items for a systematic review and meta-analysis of individual participant data: The PRISMAIPD statement., JAMA, 313, pp. 1657-1665, (2015)
  • [15] Kong Y., Lin L.L., Chen Y., Lai S., Wu H.W., Study on the mechanism of Xuebijing injection in the treatment of novel coronavirus pneumonia based on network pharmacology., World Sci Technol, 22, pp. 730-738, (2020)
  • [16] Chen H., Bai Z., Li H., Efficacy of Xuebijing injection for acute pancreatitis: A systematic review and meta-analysis of randomized controlled trials., Evid Based Complement Alternat Med, 2021, (2021)
  • [17] Wang J., Li X.J., Network pharmacology and drug discovery., Prog Physiol Sci, 42, pp. 241-245, (2011)
  • [18] Liu C.W., Liu J.Y., Research progress on pharmacological effects of quercetin., Chin J Lung Dis (Electron Ed), 13, pp. 104-106, (2020)
  • [19] Wang P., Wang W., Shi Q., Paeoniflorin ameliorates acute necrotizing pancreatitis and pancreatitis-induced acute renal injury., Mol Med Rep, 14, pp. 1123-1131, (2016)
  • [20] Fan Y.T., Yin G.J., Xiao W.Q., Rosmarinic acid attenuates sodium taurocholate-induced acute pancreatitis in rats by inhibiting nuclear factor-κB activation., Am J Chin Med, 43, pp. 1117-1135, (2015)
123